Nos combats

On the final day of the Commission on Narcotic Drugs (CND), UN member states adopted the resolution "Promoting viral hepatitis prevention and treatment among people who have used drugs". During this plenary session, Wangari Kimenia, Head of Harm reduction for Doctors of the World in Kenya, spoke on...
Gilead’s price gouging for sofosbuvir blocks millions of people from getting treatment.
© Olivier Papegnies
Faced with significant price increases for new drugs, in North and South alike, particularly drugs for cancer, hepatitis C and rare diseases, civil society in France is taking action to defend access to best-quality care for all, and to safeguard the public healthcare system. Several organisations...
World Hepatitis Summit 2017 : Declaration of the Hepatitis Community.
© Quentin Top
Doctors of the World – Médecins du Monde (MdM) made sexual and reproductive health one of its priorities for action and advocates for women’s right to control their own bodies, to have a sexual life free of coercion nor violence and to decide freely whether to have children or not, when and how...
It is no secret that the price of medicines is getting higher and higher, and that these prices are absolutely unjustified. That pharmaceutical companies make huge and contemptable profit margins on treatments for sick people, that the National Health Service cannot maintain. When it comes to...
Les nouveaux médicaments antiviraux à action directe sont certes très efficaces, mais atteignent des prix inquiétants © Reuters
We are all entitled to know about the process involved in pricing a medicine. Let’s not let pharmaceutical laboratories decide on “the price to put on a life” using profitability as criteria.
Today in the UK , doctors have to tell patients that they could cure them using a specific medicine, but cannot prescribe it because it’s too expensive. To avoid the collapse of our health service, the British Government has established selection strategies to decide which patients can benefit from...
The Pharmaceutical Price Regulation Scheme (PPRS) is the mechanism used by the UK Department of Health to ensure that the NHS has access to good quality medicines at reasonable prices. It involves a non-contractual agreement between the UK Department of Health and The Association of the British...
Global loader